Alteration of the T cell repertoire after bone marrow transplantation. 1994

D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
INSERM U211 and CHR Nantes, Institut de Biologie, France.

We investigated T cell receptor (TCR) alpha/beta and gamma/delta repertoire reconstitution after autologous and allogeneic bone marrow transplantation (BMT) in humans using 13 monoclonal antibodies directed at constant and variable regions of the TCR. The TCR gamma/delta repertoire was studied kinetically during the first month and then 1 year post-BMT whereas alpha/beta peripheral blood T lymphocytes (PBTL) were studied within the first 3 months and 1 year post-BMT. Through these two studies, we found 7 of 26 patients with over-represented TCR gamma/delta subsets during the early period post-BMT. Moreover, during this period the V gamma 9V delta 2 frequency among gamma/delta T cells was found to be higher than among normal donors. Study on TCR alpha/beta T cells also revealed abnormally expanded V-specific subset (5 of 10 patients within 3 months following BMT) demonstrating that repertoire alteration early after BMT is a general phenomenon concerning potentially all T cell subsets. More surprisingly, the alpha/beta T cell repertoire was also found to be altered late after BMT (7 of 15 patients after 1 year post-BMT presented one or more overepresented alpha/beta TCR subset). These alterations of TCR combinatorial diversity should be taken into account in understanding the immunological status of patients after BMT.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
January 1996, Human immunology,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
October 1997, Hematology and cell therapy,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
May 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
September 1995, Bone marrow transplantation,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
July 1995, Annals of the New York Academy of Sciences,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
December 1998, Blood,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
October 1983, Clinical and experimental immunology,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
January 1980, Haematology and blood transfusion,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
September 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
D Villers, and N Milpied, and J Gaschet, and F Davodeau, and M M Hallet, and M Bonneville, and H Vié
October 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Copied contents to your clipboard!